nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.24	0.329	CbGbCtD
Cefadroxil—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.182	0.25	CbGbCtD
Cefadroxil—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.137	0.188	CbGbCtD
Cefadroxil—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0955	0.131	CbGbCtD
Cefadroxil—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0739	0.101	CbGbCtD
Cefadroxil—Cefpiramide—ALB—acquired immunodeficiency syndrome	0.00089	0.256	CrCbGaD
Cefadroxil—Cefonicid—ALB—acquired immunodeficiency syndrome	0.000775	0.223	CrCbGaD
Cefadroxil—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000575	0.0022	CcSEcCtD
Cefadroxil—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000575	0.0022	CcSEcCtD
Cefadroxil—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000574	0.00219	CcSEcCtD
Cefadroxil—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000571	0.00218	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000569	0.00217	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000567	0.00217	CcSEcCtD
Cefadroxil—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000567	0.00217	CcSEcCtD
Cefadroxil—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000566	0.00216	CcSEcCtD
Cefadroxil—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000565	0.00216	CcSEcCtD
Cefadroxil—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000564	0.00215	CcSEcCtD
Cefadroxil—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.00056	0.00214	CcSEcCtD
Cefadroxil—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000559	0.00213	CcSEcCtD
Cefadroxil—Tension—Delavirdine—acquired immunodeficiency syndrome	0.000557	0.00213	CcSEcCtD
Cefadroxil—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000552	0.00211	CcSEcCtD
Cefadroxil—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000551	0.00211	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000549	0.0021	CcSEcCtD
Cefadroxil—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000549	0.0021	CcSEcCtD
Cefadroxil—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000549	0.00209	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000548	0.00209	CcSEcCtD
Cefadroxil—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000546	0.00208	CcSEcCtD
Cefadroxil—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000543	0.00207	CcSEcCtD
Cefadroxil—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00054	0.00206	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00054	0.00206	CcSEcCtD
Cefadroxil—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000538	0.00206	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000537	0.00205	CcSEcCtD
Cefadroxil—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000535	0.00204	CcSEcCtD
Cefadroxil—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000533	0.00204	CcSEcCtD
Cefadroxil—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000524	0.002	CcSEcCtD
Cefadroxil—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000524	0.002	CcSEcCtD
Cefadroxil—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000522	0.00199	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00052	0.00199	CcSEcCtD
Cefadroxil—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00052	0.00198	CcSEcCtD
Cefadroxil—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00052	0.00198	CcSEcCtD
Cefadroxil—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000519	0.00198	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000519	0.00198	CcSEcCtD
Cefadroxil—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000517	0.00197	CcSEcCtD
Cefadroxil—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000516	0.00197	CcSEcCtD
Cefadroxil—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000514	0.00196	CcSEcCtD
Cefadroxil—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000513	0.00196	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000511	0.00195	CcSEcCtD
Cefadroxil—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00051	0.00195	CcSEcCtD
Cefadroxil—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.00051	0.00195	CcSEcCtD
Cefadroxil—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00051	0.00195	CcSEcCtD
Cefadroxil—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000506	0.00193	CcSEcCtD
Cefadroxil—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000506	0.00193	CcSEcCtD
Cefadroxil—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000505	0.00193	CcSEcCtD
Cefadroxil—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000505	0.00193	CcSEcCtD
Cefadroxil—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000505	0.00193	CcSEcCtD
Cefadroxil—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000504	0.00192	CcSEcCtD
Cefadroxil—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000503	0.00192	CcSEcCtD
Cefadroxil—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000503	0.00192	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000502	0.00192	CcSEcCtD
Cefadroxil—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000502	0.00192	CcSEcCtD
Cefadroxil—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000502	0.00192	CcSEcCtD
Cefadroxil—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000502	0.00191	CcSEcCtD
Cefadroxil—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000502	0.00191	CcSEcCtD
Cefadroxil—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.0005	0.00191	CcSEcCtD
Cefadroxil—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000497	0.0019	CcSEcCtD
Cefadroxil—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000494	0.00189	CcSEcCtD
Cefadroxil—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000494	0.00189	CcSEcCtD
Cefadroxil—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00049	0.00187	CcSEcCtD
Cefadroxil—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000486	0.00186	CcSEcCtD
Cefadroxil—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000485	0.00185	CcSEcCtD
Cefadroxil—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000484	0.00185	CcSEcCtD
Cefadroxil—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000484	0.00185	CcSEcCtD
Cefadroxil—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000476	0.00182	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000476	0.00182	CcSEcCtD
Cefadroxil—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000474	0.00181	CcSEcCtD
Cefadroxil—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000473	0.00181	CcSEcCtD
Cefadroxil—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000472	0.0018	CcSEcCtD
Cefadroxil—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000472	0.0018	CcSEcCtD
Cefadroxil—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000469	0.00179	CcSEcCtD
Cefadroxil—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000469	0.00179	CcSEcCtD
Cefadroxil—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000467	0.00178	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000467	0.00178	CcSEcCtD
Cefadroxil—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000465	0.00177	CcSEcCtD
Cefadroxil—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000465	0.00177	CcSEcCtD
Cefadroxil—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000464	0.00177	CcSEcCtD
Cefadroxil—Rash—Didanosine—acquired immunodeficiency syndrome	0.000461	0.00176	CcSEcCtD
Cefadroxil—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000461	0.00176	CcSEcCtD
Cefadroxil—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00046	0.00176	CcSEcCtD
Cefadroxil—Headache—Didanosine—acquired immunodeficiency syndrome	0.000458	0.00175	CcSEcCtD
Cefadroxil—Cefoperazone—ALB—acquired immunodeficiency syndrome	0.000457	0.131	CrCbGaD
Cefadroxil—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000457	0.00174	CcSEcCtD
Cefadroxil—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000456	0.00174	CcSEcCtD
Cefadroxil—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000455	0.00174	CcSEcCtD
Cefadroxil—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000455	0.00174	CcSEcCtD
Cefadroxil—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000454	0.00173	CcSEcCtD
Cefadroxil—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000454	0.00173	CcSEcCtD
Cefadroxil—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000451	0.00172	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000451	0.00172	CcSEcCtD
Cefadroxil—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00045	0.00172	CcSEcCtD
Cefadroxil—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00045	0.00172	CcSEcCtD
Cefadroxil—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000449	0.00171	CcSEcCtD
Cefadroxil—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000448	0.00171	CcSEcCtD
Cefadroxil—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000447	0.00171	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000443	0.00169	CcSEcCtD
Cefadroxil—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000442	0.00169	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000442	0.00169	CcSEcCtD
Cefadroxil—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000441	0.00168	CcSEcCtD
Cefadroxil—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000438	0.00167	CcSEcCtD
Cefadroxil—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000438	0.00167	CcSEcCtD
Cefadroxil—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000436	0.00166	CcSEcCtD
Cefadroxil—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000436	0.00166	CcSEcCtD
Cefadroxil—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000435	0.00166	CcSEcCtD
Cefadroxil—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000434	0.00166	CcSEcCtD
Cefadroxil—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000434	0.00166	CcSEcCtD
Cefadroxil—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000433	0.00165	CcSEcCtD
Cefadroxil—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000431	0.00164	CcSEcCtD
Cefadroxil—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00043	0.00164	CcSEcCtD
Cefadroxil—SLC15A1—digestive system—acquired immunodeficiency syndrome	0.000428	0.0705	CbGeAlD
Cefadroxil—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000428	0.00163	CcSEcCtD
Cefadroxil—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000427	0.00163	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000422	0.00161	CcSEcCtD
Cefadroxil—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000421	0.00161	CcSEcCtD
Cefadroxil—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00042	0.0016	CcSEcCtD
Cefadroxil—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00042	0.0016	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000419	0.0016	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000418	0.0016	CcSEcCtD
Cefadroxil—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000418	0.0016	CcSEcCtD
Cefadroxil—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000418	0.00159	CcSEcCtD
Cefadroxil—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000414	0.00158	CcSEcCtD
Cefadroxil—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000414	0.00158	CcSEcCtD
Cefadroxil—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000413	0.00158	CcSEcCtD
Cefadroxil—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000412	0.00157	CcSEcCtD
Cefadroxil—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000412	0.00157	CcSEcCtD
Cefadroxil—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000411	0.00157	CcSEcCtD
Cefadroxil—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000408	0.00156	CcSEcCtD
Cefadroxil—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000407	0.00156	CcSEcCtD
Cefadroxil—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000405	0.00155	CcSEcCtD
Cefadroxil—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000405	0.00155	CcSEcCtD
Cefadroxil—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000405	0.00154	CcSEcCtD
Cefadroxil—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000404	0.00154	CcSEcCtD
Cefadroxil—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000403	0.00154	CcSEcCtD
Cefadroxil—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000401	0.00153	CcSEcCtD
Cefadroxil—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000401	0.00153	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.0004	0.00153	CcSEcCtD
Cefadroxil—Rash—Stavudine—acquired immunodeficiency syndrome	0.0004	0.00153	CcSEcCtD
Cefadroxil—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.0004	0.00153	CcSEcCtD
Cefadroxil—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000399	0.00152	CcSEcCtD
Cefadroxil—Headache—Stavudine—acquired immunodeficiency syndrome	0.000397	0.00152	CcSEcCtD
Cefadroxil—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000397	0.00152	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000396	0.00151	CcSEcCtD
Cefadroxil—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000396	0.00151	CcSEcCtD
Cefadroxil—Rash—Abacavir—acquired immunodeficiency syndrome	0.000394	0.0015	CcSEcCtD
Cefadroxil—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000394	0.0015	CcSEcCtD
Cefadroxil—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000394	0.0015	CcSEcCtD
Cefadroxil—Headache—Abacavir—acquired immunodeficiency syndrome	0.000392	0.00149	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000391	0.00149	CcSEcCtD
Cefadroxil—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00039	0.00149	CcSEcCtD
Cefadroxil—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00039	0.00149	CcSEcCtD
Cefadroxil—Ampicillin—ALB—acquired immunodeficiency syndrome	0.000388	0.112	CrCbGaD
Cefadroxil—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000385	0.00147	CcSEcCtD
Cefadroxil—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000385	0.00147	CcSEcCtD
Cefadroxil—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000383	0.00146	CcSEcCtD
Cefadroxil—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000383	0.00146	CcSEcCtD
Cefadroxil—SLC15A2—retina—acquired immunodeficiency syndrome	0.000381	0.0628	CbGeAlD
Cefadroxil—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000381	0.00145	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000379	0.00145	CcSEcCtD
Cefadroxil—SLC15A1—vagina—acquired immunodeficiency syndrome	0.000378	0.0623	CbGeAlD
Cefadroxil—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000378	0.00144	CcSEcCtD
Cefadroxil—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000378	0.00144	CcSEcCtD
Cefadroxil—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000377	0.00144	CcSEcCtD
Cefadroxil—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000377	0.00144	CcSEcCtD
Cefadroxil—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000377	0.00144	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000376	0.00144	CcSEcCtD
Cefadroxil—Cefazolin—ALB—acquired immunodeficiency syndrome	0.000375	0.108	CrCbGaD
Cefadroxil—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000371	0.00142	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00037	0.00141	CcSEcCtD
Cefadroxil—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000368	0.00141	CcSEcCtD
Cefadroxil—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000368	0.0014	CcSEcCtD
Cefadroxil—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000367	0.0014	CcSEcCtD
Cefadroxil—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000367	0.0014	CcSEcCtD
Cefadroxil—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000367	0.0014	CcSEcCtD
Cefadroxil—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000365	0.00139	CcSEcCtD
Cefadroxil—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000363	0.00139	CcSEcCtD
Cefadroxil—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000363	0.00139	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000359	0.00137	CcSEcCtD
Cefadroxil—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000357	0.00136	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000356	0.00136	CcSEcCtD
Cefadroxil—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000351	0.00134	CcSEcCtD
Cefadroxil—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000351	0.00134	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000351	0.00134	CcSEcCtD
Cefadroxil—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00035	0.00134	CcSEcCtD
Cefadroxil—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000348	0.00133	CcSEcCtD
Cefadroxil—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000348	0.00133	CcSEcCtD
Cefadroxil—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000347	0.00133	CcSEcCtD
Cefadroxil—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000347	0.00132	CcSEcCtD
Cefadroxil—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000345	0.00132	CcSEcCtD
Cefadroxil—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000343	0.00131	CcSEcCtD
Cefadroxil—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000342	0.0013	CcSEcCtD
Cefadroxil—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000341	0.0013	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00034	0.0013	CcSEcCtD
Cefadroxil—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000339	0.00129	CcSEcCtD
Cefadroxil—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.00129	CcSEcCtD
Cefadroxil—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.00129	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000337	0.00129	CcSEcCtD
Cefadroxil—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000333	0.00127	CcSEcCtD
Cefadroxil—SLC22A5—retina—acquired immunodeficiency syndrome	0.000332	0.0546	CbGeAlD
Cefadroxil—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000332	0.00127	CcSEcCtD
Cefadroxil—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000328	0.00125	CcSEcCtD
Cefadroxil—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000328	0.00125	CcSEcCtD
Cefadroxil—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000328	0.00125	CcSEcCtD
Cefadroxil—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.00125	CcSEcCtD
Cefadroxil—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.00125	CcSEcCtD
Cefadroxil—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000326	0.00124	CcSEcCtD
Cefadroxil—Rash—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00123	CcSEcCtD
Cefadroxil—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00123	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000322	0.00123	CcSEcCtD
Cefadroxil—Headache—Indinavir—acquired immunodeficiency syndrome	0.000321	0.00123	CcSEcCtD
Cefadroxil—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00032	0.00122	CcSEcCtD
Cefadroxil—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.00121	CcSEcCtD
Cefadroxil—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.00121	CcSEcCtD
Cefadroxil—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000313	0.00119	CcSEcCtD
Cefadroxil—Cefalotin—ALB—acquired immunodeficiency syndrome	0.000312	0.0896	CrCbGaD
Cefadroxil—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.00119	CcSEcCtD
Cefadroxil—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.00119	CcSEcCtD
Cefadroxil—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000308	0.00118	CcSEcCtD
Cefadroxil—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.00117	CcSEcCtD
Cefadroxil—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000307	0.00117	CcSEcCtD
Cefadroxil—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000306	0.00117	CcSEcCtD
Cefadroxil—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.00117	CcSEcCtD
Cefadroxil—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000305	0.00116	CcSEcCtD
Cefadroxil—SLC22A6—brain—acquired immunodeficiency syndrome	0.000304	0.0501	CbGeAlD
Cefadroxil—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.00116	CcSEcCtD
Cefadroxil—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000304	0.00116	CcSEcCtD
Cefadroxil—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000303	0.00116	CcSEcCtD
Cefadroxil—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000296	0.00113	CcSEcCtD
Cefadroxil—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000295	0.00113	CcSEcCtD
Cefadroxil—SLC22A8—blood—acquired immunodeficiency syndrome	0.000294	0.0483	CbGeAlD
Cefadroxil—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00112	CcSEcCtD
Cefadroxil—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00112	CcSEcCtD
Cefadroxil—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00111	CcSEcCtD
Cefadroxil—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.00111	CcSEcCtD
Cefadroxil—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000291	0.0479	CbGeAlD
Cefadroxil—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00029	0.00111	CcSEcCtD
Cefadroxil—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00029	0.00111	CcSEcCtD
Cefadroxil—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000288	0.0011	CcSEcCtD
Cefadroxil—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000284	0.00108	CcSEcCtD
Cefadroxil—Cephalexin—ALB—acquired immunodeficiency syndrome	0.000283	0.0814	CrCbGaD
Cefadroxil—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000282	0.00108	CcSEcCtD
Cefadroxil—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00108	CcSEcCtD
Cefadroxil—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.00106	CcSEcCtD
Cefadroxil—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000275	0.00105	CcSEcCtD
Cefadroxil—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000273	0.00104	CcSEcCtD
Cefadroxil—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000273	0.00104	CcSEcCtD
Cefadroxil—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00103	CcSEcCtD
Cefadroxil—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00103	CcSEcCtD
Cefadroxil—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.00103	CcSEcCtD
Cefadroxil—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000269	0.00103	CcSEcCtD
Cefadroxil—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.001	CcSEcCtD
Cefadroxil—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00026	0.000994	CcSEcCtD
Cefadroxil—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.000993	CcSEcCtD
Cefadroxil—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.000992	CcSEcCtD
Cefadroxil—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.000987	CcSEcCtD
Cefadroxil—SLC15A2—blood—acquired immunodeficiency syndrome	0.000255	0.042	CbGeAlD
Cefadroxil—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.000972	CcSEcCtD
Cefadroxil—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.000955	CcSEcCtD
Cefadroxil—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.000947	CcSEcCtD
Cefadroxil—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.000947	CcSEcCtD
Cefadroxil—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.000941	CcSEcCtD
Cefadroxil—SLC15A2—spinal cord—acquired immunodeficiency syndrome	0.000246	0.0405	CbGeAlD
Cefadroxil—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.000936	CcSEcCtD
Cefadroxil—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000238	0.0392	CbGeAlD
Cefadroxil—SLC15A2—vagina—acquired immunodeficiency syndrome	0.000236	0.0389	CbGeAlD
Cefadroxil—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.000893	CcSEcCtD
Cefadroxil—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000233	0.0383	CbGeAlD
Cefadroxil—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000229	0.0378	CbGeAlD
Cefadroxil—SLC15A2—lung—acquired immunodeficiency syndrome	0.000224	0.0368	CbGeAlD
Cefadroxil—SLC22A5—blood—acquired immunodeficiency syndrome	0.000222	0.0365	CbGeAlD
Cefadroxil—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000214	0.0352	CbGeAlD
Cefadroxil—SLC15A2—nervous system—acquired immunodeficiency syndrome	0.000207	0.0341	CbGeAlD
Cefadroxil—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000206	0.0339	CbGeAlD
Cefadroxil—SLC15A2—central nervous system—acquired immunodeficiency syndrome	0.000199	0.0328	CbGeAlD
Cefadroxil—SLC22A5—lung—acquired immunodeficiency syndrome	0.000194	0.032	CbGeAlD
Cefadroxil—SLC22A8—brain—acquired immunodeficiency syndrome	0.000182	0.03	CbGeAlD
Cefadroxil—SLC15A2—brain—acquired immunodeficiency syndrome	0.000158	0.0261	CbGeAlD
Cefadroxil—SLC15A2—lymph node—acquired immunodeficiency syndrome	0.000153	0.0252	CbGeAlD
Cefadroxil—SLC22A5—brain—acquired immunodeficiency syndrome	0.000138	0.0227	CbGeAlD
Cefadroxil—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.000133	0.0219	CbGeAlD
